MINNEAPOLIS, Aug. 16, 2019 /PRNewswire/ -- CVRx, Inc., a private medical device company, announced today that it has received Premarket Approval (PMA) from the United States Food and Drug Administration (FDA) to market its BAROSTIM NEO device for heart failure in the United States. The FDA's Center for Devices and Radiological Health

STOCKHOLM, Aug. 16, 2019 /PRNewswire/ -- Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today the acceptance of an oral late breaking presentation providing updated melflufen data from the Phase 2 pivotal OP-106 HORIZON study as well as two poster presentations at the 17th International Myeloma Workshop (IMW) meeting (September 12-15,

PHILADELPHIA, Aug. 16, 2019 /PRNewswire/ -- New research shows that brief parent-targeted interventions in the primary care setting can increase communication between parents and their teens about sexual and alcohol behavior. This method may serve as an important strategy for parents to influence adolescent behaviors and health outcomes.

ST. PETERSBURG, Fla., Aug. 16, 2019 /PRNewswire/ -- On April 4, 2019, the daughter of a patient who died in a Pinellas County, Florida hospital sued St. Anthony's Hospital, Inc. and Baycare Health System, Inc. The complaint alleges that the defendants were vicariously responsible for the slip and fall that ca

DAYTON, Ohio, Aug. 16, 2019 /PRNewswire/ -- People in their 60s who are strong in mind, body and spirit have a chance to be "pin ups" in a 2020 Dayton 60 Strong calendar. Proceeds from calendar sales will benefit the

NEW YORK, Aug. 16, 2019 /PRNewswire/ -- Inc. magazine revealed that NativePath, formally known as Lexicon Health, is No. 655 on its annual Inc. 5000 list, the most prestigious ranking of the nation's fastest-growing private companies. The list represents a unique look at the most successful companies within the American economy's most dynamic segment—its ind

CHINO HILLS, Calif., Aug. 16, 2019 /PRNewswire/ -- Fit Body Boot Camp, the world's fastest-growing fitness boot camp franchise, announced today that it has been recognized for t

NEW YORK, Aug. 16, 2019 /PRNewswire/ -- The many voices of patients with IgA nephropathy, a chronic kidney disease, will come together on Monday, August 19, during an

NORTH CHICAGO, Ill., Aug. 16, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved RINVOQ™ (upadacitinib), a 15 mg, once-daily oral Janus kinase (JAK) inhibitor, for the treatment of adults with moderately to severely active rheumato

TROY, Mich., Aug. 16, 2019 /PRNewswire/ -- Beaumont Hospital, Troy has once again achieved the highest honor